PremiumCompany AnnouncementsAstraZeneca Expands Real‑World Evidence for Acalabrutinib in CLL22h agoAZN
PremiumCompany AnnouncementsAstraZeneca’s Danicopan Korea Study: Real-World Data That Could Shape AZN’s Rare Disease Edge22h agoAZN
PremiumCompany AnnouncementsShell Advances Capital Return Drive with Further Multivenue Share Buy-Back2d ago